A01K 2267/0306
Animal model for genetic diseases
A01K2267/0306 (Animal model for genetic diseases) appears on 896 US grants and 1,636 published applications in this corpus.
Search patents in A01K- Granted patents
- 896
- Published applications
- 1,636
- Assignees
- 762
- Inventors
- 3,394
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 12 | 0 |
| 1997 | 21 | 0 |
| 1998 | 38 | 0 |
| 1999 | 32 | 0 |
| 2000 | 28 | 0 |
| 2001 | 37 | 6 |
| 2002 | 26 | 64 |
| 2003 | 40 | 86 |
| 2004 | 27 | 58 |
| 2005 | 17 | 70 |
| 2006 | 30 | 56 |
| 2007 | 34 | 50 |
| 2008 | 22 | 54 |
| 2009 | 18 | 51 |
| 2010 | 30 | 42 |
| 2011 | 22 | 51 |
| 2012 | 18 | 30 |
| 2013 | 15 | 23 |
| 2014 | 20 | 28 |
| 2015 | 14 | 29 |
| 2016 | 17 | 42 |
| 2017 | 27 | 44 |
| 2018 | 19 | 60 |
| 2019 | 26 | 80 |
| 2020 | 30 | 104 |
| 2021 | 23 | 105 |
| 2022 | 32 | 119 |
| 2023 | 44 | 120 |
| 2024 | 57 | 117 |
| 2025 | 65 | 94 |
| 2026 | 47 | 53 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene22 Sep 2026US 12,742,179 B2National Jewish Health
- Methods of treating mitochondrial disorders1 Sep 2026US 12,723,062 B2The Regents of the University of California
- Neurodegenerative and amyotrophic model animal25 Aug 2026US 12,714,076 B2Tokyo Metropolitan Institute of Medical Science
- Pharmaceutical composition for treating degenerative brain disease, including glycine transporter as active ingredient18 Aug 2026US 12,708,657 B2Amyloid Solution Inc.
- KIR 7.1 gene therapy vectors and methods of using the same18 Aug 2026US 12,709,760 B2Wisconsin Alumni Research Foundation
- Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis Comprising a Corticosteroid or Use Thereof27 Aug 2026US 2026/0248964 A1Intellia Therapeutics, Inc.
- Induction of Immune Tolerance by AAV Vector Comprising the Combination of a Liver Detargeted Capsid and a Tandem Liver-Muscle Specific Promoter27 Aug 2026US 2026/0250712 A1Genethon
- Methods And Uses Involving Aquaporin-5 (AQP5)20 Aug 2026US 2026/0243770 A1Agency for Science, Technology and Research
- Nucleic acid vector comprising a coding sequence of the epm2a gene13 Aug 2026US 2026/0234661 A1
- Treatment of krabbe disease with umbilical cord blood transplantation (ucbt) and increased galactocerebrosidase (galc) expression6 Aug 2026US 2026/0224639 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
Most cited
By later US patents
- Growth hormone antagonists389US 5,350,836 AOhio University · 1994
- Human CTLA-4 antibodies300US 6,984,720 B1Medarex, Inc. · 2006
- Gene therapy vector for cystic fibrosis226US 5,240,846 AThe Regents of the University of Michigan · 1993
- Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease201US 5,387,742 AScios Nova Inc. · 1995
- Methods for monitoring cellular processing of .beta.-amyloid precursor protein167US 5,441,870 AAthena Neurosciences, Inc. · 1995